| Cancer |
DYRK2 |
Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, transcript variant 1 |
2.04 |
0.0056 |
|
CDC14A |
CDC14 cell division cycle 14 homologue A (Saccharomyces cerevisiae), transcript variant 3 |
2.05 |
0.0002 |
|
HBD |
Haemoglobin δ |
2.12 |
0.0025 |
|
GSTM1 |
Glutathione S-transferase M1, transcript variant 1 |
2.16 |
0.0355 |
|
MGST1 |
Microsomal glutathione S-transferase 1, transcript variant 1b |
2.19 |
0.0190 |
|
BHLHB9 |
Basic helix–loop–helix domain containing, class B, 9 |
2.20 |
0.0500 |
|
CTAGE5 |
CTAGE family, member 5, transcript variant 4 |
2.25 |
0.0036 |
|
PRPH |
Peripherin |
2.27 |
0.0317 |
|
SF1 |
Splicing factor 1, transcript variant 4 |
2.30 |
0.0449 |
|
SMPD3 |
Sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
2.38 |
0.0210 |
|
GSTM3 |
Glutathione S-transferase M3 (brain) |
2.44 |
0.0008 |
|
FOLR3 |
Folate receptor 3 (γ) |
2.45 |
0.0461 |
|
HTRA1 |
Htra serine peptidase 1 |
2.55 |
0.0441 |
|
TFF3 |
Trefoil factor 3 (intestinal) |
2.68 |
0.0348 |
|
HRK |
Harakiri, BCL2 interacting protein (contains only BH3 domain) |
2.82 |
0.0375 |
|
ALOX15 |
Homo sapiens arachidonate 15-lipoxygenase |
2.96 |
0.0171 |
|
OLIG2 |
Oligodendrocyte lineage transcription factor 2 |
2.96 |
0.0010 |
|
AMACR |
α-Methylacyl-coa racemase, transcript variant 1 |
0.50 |
0.0263 |
|
PARP10 |
Poly (ADP-ribose) polymerase family, member 10 |
0.49 |
0.0012 |
|
CXCR7 |
Chemokine (C-X-C motif) receptor 7, transcript variant 1 |
0.48 |
0.0307 |
|
CXCR7 |
Chemokine (C-X-C motif) receptor 7 |
0.50 |
0.0004 |
|
HOXB2 |
Homeobox B2 |
0.47 |
0.0279 |
|
PARP9 |
Poly(ADP-ribose) polymerase family, member 9 |
0.46 |
0.0019 |
|
OSM |
Oncostatin M |
0.44 |
0.0126 |
|
RASSF5 |
Ras association (ralgds/AF-6) domain family member 5, transcript variant 3 |
0.32 |
0.0321 |
|
PPP2R3B |
Protein phosphatase 2 (formerly 2A), regulatory subunit B′′, β, transcript variant 2 |
0.25 |
0.0338 |
|
GATA2 |
GATA binding protein 2 |
0.23 |
0.0085 |
| Immunity |
CLC |
Charcot-Leyden crystal protein |
2.12 |
0.0065 |
|
IL5RA |
Interleukin 5 receptor, α, transcript variant 6 |
2.13 |
0.0126 |
|
EMR4 |
Egf-like module containing, mucin-like, hormone receptor-like 4 |
4.14 |
0.0002 |
|
CCL23 |
Chemokine (C-C motif) ligand 23, transcript variant ckβ8-1 |
6.26 |
0.0440 |
|
PLSCR1 |
Phospholipid scramblase 1 |
0.50 |
0.0456 |
|
CD8B |
CD8b molecule, transcript variant 5 |
0.50 |
0.0006 |
|
TRIM5 |
Tripartite motif-containing 5, transcript variant α |
0.49 |
0.0060 |
|
TRIM22 |
Tripartite motif-containing 22 |
0.48 |
0.0062 |
|
CD38 |
CD38 molecule |
0.48 |
0.0437 |
|
FCGR1B |
Fc fragment of igg, high affinity Ib, receptor (CD64), transcript variant 2 |
0.48 |
0.0057 |
|
IFI35 |
Interferon-induced protein 35 |
0.47 |
0.0059 |
|
IFIT2 |
Interferon-induced protein with tetratricopeptide repeats 2 |
0.47 |
0.0276 |
|
IRF7 |
Interferon regulatory factor 7, transcript variant b |
0.43 |
0.0022 |
|
IRF7 |
Interferon regulatory factor 7, transcript variant b |
0.49 |
0.0004 |
|
DLL1 |
δ-like 1 (Drosophila) |
0.43 |
0.0491 |
|
EVI2A |
Ecotropic viral integration site 2A, transcript variant 1 |
0.40 |
0.0252 |
|
MX1 |
Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
0.40 |
0.0086 |
|
C1QB |
Complement component 1, q subcomponent, B chain |
0.35 |
0.0453 |
|
OAS1 |
2′,5′-Oligoadenylate synthetase 1, 40/46 kDa, transcript variant 2 |
0.21 |
0.0010 |
|
OAS1 |
2′,5′-Oligoadenylate synthetase 1, 40/46 kDa, transcript variant 3 |
0.45 |
0.0371 |
|
TNFRSF18 |
Tumour necrosis factor receptor superfamily, member 18, transcript variant 3 |
0.31 |
0.0028 |
|
IFIT3 |
Interferon-induced protein with tetratricopeptide repeats 3 |
0.24 |
0.0051 |
|
IFIT3 |
Interferon-induced protein with tetratricopeptide repeats 3 |
0.34 |
0.0003 |
|
IFIT3 |
Interferon-induced protein with tetratricopeptide repeats 3 |
0.36 |
0.0002 |
|
IFI6 |
Interferon, α-inducible protein 6, transcript variant 2 |
0.29 |
0.0034 |
|
MS4A2 |
Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; β polypeptide) |
0.27 |
0.0046 |
|
ISG15 |
ISG15 ubiquitin-like modifier |
0.23 |
0.0280 |
|
IFIT1 |
Interferon-induced protein with tetratricopeptide repeats 1, transcript variant 2 |
0.23 |
0.0388 |
|
SERPING1 |
Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, transcript variant 2 |
0.19 |
0.0233 |
|
TMEM176B |
Transmembrane protein 176B |
0.16 |
0.0012 |
|
TMEM176A |
Transmembrane protein 176A |
0.10 |
0.0005 |
| Other |
SERINC5 |
Serine incorporator 5 |
2.04 |
0.0214 |
|
PRSS33 |
Protease, serine, 33 |
2.04 |
0.0059 |
|
ZNF493 |
Zinc-finger protein 493, transcript variant 3 |
2.04 |
0.0088 |
|
GYPE |
Glycophorin E, transcript variant 1 |
2.44 |
0.0002 |
|
ZNF121 |
Zinc-finger protein 121 |
2.69 |
0.0159 |
|
NEBL |
Nebulette, transcript variant 1 |
2.73 |
0.0147 |
|
GYPB |
Glycophorin B (MNS blood group) |
2.78 |
0.0001 |
|
KCNMB4 |
Potassium large conductance calcium-activated channel, subfamily M, β member 4 |
2.97 |
0.0300 |
|
NAV1 |
Neuron navigator 1 |
5.92 |
0.0402 |
|
TMEM100 |
Transmembrane protein 100, transcript variant 2 |
7.76 |
0.0300 |
|
GBP4 |
Guanylate binding protein 4 |
0.49 |
0.0079 |
|
LFNG |
LFNG O-fucosylpeptide 3-β-N-acetylglucosaminyltransferase, transcript variant 2 |
0.49 |
0.0322 |
|
RGPD2 |
RANBP2-like and GRIP domain containing 2 (RGPD2) XM_001134112 XM_001134114 XM_001134116
|
0.45 |
0.0279 |
|
RPS6KA2 |
Ribosomal protein S6 kinase, 90 kDa, polypeptide 2, transcript variant 2 |
0.45 |
0.0216 |
|
ARHGAP12 |
Rho GTPase activating protein 12 |
0.44 |
0.0208 |
|
DHRS9 |
Dehydrogenase/reductase (SDR family) member 9, transcript variant 2 |
0.44 |
0.0431 |
|
GBP1 |
Guanylate binding protein 1, interferon-inducible, 67 kDa |
0.42 |
0.0008 |
|
HERC5 |
Hect domain and RLD 5 |
0.40 |
0.0107 |
|
GCH1 |
GTP cyclohydrolase 1, transcript variant 3 |
0.39 |
0.0106 |
|
LMTK2 |
Lemur tyrosine kinase 2 |
0.39 |
0.0340 |
|
SLC34A1 |
Solute carrier family 34 (sodium phosphate), member 1 |
0.37 |
0.0260 |
|
OASL |
2′-5′-Oligoadenylate synthetase-like, transcript variant 1 |
0.30 |
0.0026 |
|
OASL |
2′-5′-Oligoadenylate synthetase-like, transcript variant 2 |
0.36 |
0.0102 |
|
TBRG4 |
Transforming growth factor β regulator 4, transcript variant 1 |
0.33 |
0.0280 |
|
HDC |
Histidine decarboxylase |
0.31 |
0.0459 |
|
GPRC5C |
G protein-coupled receptor, family C, group 5, member C, transcript variant 2 |
0.22 |
0.0369 |
| Undefined |
PHF20L1 |
PHD finger protein 20-like 1, transcript variant 2 |
2.01 |
0.0104 |
|
RUNDC2A |
RUN domain containing 2A |
2.02 |
0.0148 |
|
GTSF1 |
Gametocyte specific factor 1 |
2.07 |
0.0003 |
|
MGC26718 |
Similar to ankyrin repeat domain 20A |
2.32 |
0.0342 |
|
KIAA0367 |
Kiaa0367 |
2.78 |
0.0074 |
|
C17ORF97 |
Chromosome 17 open reading frame 97 |
3.42 |
0.0117 |
|
MOBK1B |
MOB1, Mps One Binder kinase activator-like 1B (yeast) |
0.47 |
0.0327 |
|
FAM26F |
Family with sequence similarity 26, member F |
0.43 |
0.0025 |
|
DDX60 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
0.43 |
0.0295 |
|
CPA3 |
Carboxypeptidase A3 (mast cell) |
0.38 |
0.0478 |
|
BATF2 |
Basic leucine zipper transcription factor, ATF-like 2 |
0.35 |
0.0218 |
|
SPRYD5 |
SPRY domain containing 5 |
0.29 |
0.0062 |
|
SAMD8 |
Sterile α motif domain containing 8 |
0.22 |
0.0462 |
